本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ocular Therapeutix

5.57
-0.2900-4.95%
盤後:5.600.0300+0.54%19:30 EST
成交量:289.54萬
成交額:1,637.75萬
市值:12.26億
市盈率:-3.82
高:5.95
開:5.76
低:5.54
收:5.86
52周最高:16.44
52周最低:5.54
股本:2.20億
流通股本:1.83億
量比:0.76
換手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-1.4588
每股收益(LYR):-1.4203
淨資產收益率:-93.48%
總資產收益率:-42.19%
市淨率:2.78
市盈率(LYR):-3.92

資料載入中...

2026/11/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/11/09

重要事件披露

Form 8-K - Current report
2026/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/09

重要事件披露

Form 8-K - Current report
2026/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/10/16

重要事件披露

Form 8-K - Current report
2026/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/30

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/12

重要事件披露

Form 8-K - Current report
2026/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities